[1]洪日成.胰岛素不同给药方式对2型糖尿病患者血糖控制效果及低血糖发生率的影响[J].医学信息,2024,37(17):109-112.[doi:10.3969/j.issn.1006-1959.2024.17.022]
　HONG Ri-cheng.Effect of Different Administration Methods of Insulin on Blood Glucose Controland Incidence of Hypoglycemia in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2024,37(17):109-112.[doi:10.3969/j.issn.1006-1959.2024.17.022]
点击复制

胰岛素不同给药方式对2型糖尿病患者血糖控制效果及低血糖发生率的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年17期
页码:
109-112
栏目:
论著
出版日期:
2024-09-01

文章信息/Info

Title:
Effect of Different Administration Methods of Insulin on Blood Glucose Controland Incidence of Hypoglycemia in Patients with Type 2 Diabetes Mellitus
文章编号:
1006-1959（2024）17-0109-04
作者:
洪日成
余干县人民医院药剂科，江西 余干 335100
Author(s):
HONG Ri-cheng
Pharmacy Department of Yugan County People’s Hospital,Yugan 335100,Jiangxi,China
关键词:
2型糖尿病; 持续皮下胰岛素输注; 多次胰岛素注射; 血糖控制效果; 低血糖
Keywords:
Type 2 diabetes mellitus; Continuous subcutaneous insulin infusion; Multiple insulin injections; Blood glucose control effect; Hypoglycemia
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2024.17.022
文献标志码:
A
摘要:
目的 研究胰岛素不同给药方式对2型糖尿病（T2DM）患者血糖控制效果及低血糖发生率的影响。方法 以2020年5月-2023年5月余干县人民医院收治的60例T2DM患者为研究对象，行随机数字表法分为CSII组与MDI组，各30例。CSII组给予持续皮下胰岛素输注（CSII）治疗，MDI组则应用多次胰岛素注射（MDI）治疗，比较两组血糖控制效果（血糖达标率、血糖达标时间）、血糖水平[糖化血红蛋白（HbA1c）、空腹血糖（FPG）、餐后2 h血糖（2hPBG）]、血糖波动情况[最大血糖波动幅度（LAGE）、餐后血糖波动幅度（PPGE）]、胰岛功能[空腹胰岛素（FINS）、胰岛素抵抗指数（HOMA-IR）]及不良反应。结果 两组血糖达标率比较，差异无统计学意义（P＞0.05），但CSII组血糖达标时间短于MDI组（P＜0.05）。两组治疗后血糖水平（HbA1c、FPG、2hPBG）均低于治疗前，且CSII组治疗后血糖水平（HbA1c、FPG、2hPBG）低于MDI组（P＜0.05）。CSII组LAGE、PPGE小于MDI组（P＜0.05）。两组治疗后FINS高于治疗前，HOMA-IR低于治疗前，且CSII组FINS高于MDI组，HOMA-IR低于MDI组（P＜0.05）。CSII组不良反应发生率低于MDI组（P＜0.05）。结论 CSII与MDI均可控制T2DM患者的血糖水平，其中CSII血糖达标时间更短、降糖作用更好，可减少日间血糖波动，改善患者胰岛功能，降低不良反应发生风险。
Abstract:
Objective To study the effect of different insulin administration methods on blood glucose control and the incidence of hypoglycemia in patients with type 2 diabetes mellitus (T2DM).Methods Sixty patients with T2DM admitted to Yugan County People’s Hospital from May 2020 to May 2023 were randomly divided into CSII group and MDI group, with 30 patients in each group. The CSII group was treated with continuous subcutaneous insulin infusion (CSII), and the MDI group was treated with multiple insulin injections (MDI). The blood glucose control effect (blood glucose compliance rate, blood glucose compliance time), blood glucose level [glycosylated hemoglobin (HbA1c), fasting blood glucose (FPG), 2-h postprandial blood glucose (2hPBG)], blood glucose fluctuation [largest amplitude of glycemic excursion (LAGE), postprandial glucose excursions (PPGE)], islet function [fasting insulin (FINS), insulin resistance index (HOMA-IR)] and adverse reactions were compared between the two groups.Results There was no significant difference in blood glucose compliance rate between the two groups (P>0.05), but the blood glucose compliance time of CSII group was shorter than that of MDI group (P<0.05). The blood glucose levels (HbA1c, FPG, 2hPBG) of the two groups after treatment were lower than those before treatment, and the blood glucose levels (HbA1c, FPG, 2hPBG) of the CSII group after treatment were lower than those of the MDI group (P<0.05). LAGE and PPGE in CSII group were lower than those in MDI group (P<0.05). After treatment, FINS in the two groups was higher than that before treatment, HOMA-IR was lower than that before treatment, and FINS in the CSII group was higher than that in the MDI group, HOMA-IR was lower than that in the MDI group (P<0.05). The incidence of adverse reactions in the CSII group was lower than that in the MDI group (P<0.05).Conclusion Both CSII and MDI can control the blood glucose level of T2DM patients. Among them, CSII has shorter blood glucose compliance time and better hypoglycemic effect, which can reduce daytime blood glucose fluctuations, improve islet function and reduce the risk of adverse reactions.

参考文献/References:

[1]田辛梓,谢晖.胰岛素泵持续注射与胰岛素皮下注射两种治疗方式对妊娠期糖尿病患者的治疗疗效及对妊娠结局的影响研究[J].贵州医药,2022,46(8):1201-1202.[2]徐炜炜,张红英.胰岛素不同治疗方案对妊娠期糖尿病的影响[J].中国妇幼健康研究,2021,32(9):1349-1353.[3]吴钢,张敏,段雨函.不同胰岛素治疗方式对AECOPD合并2型糖尿病患者的疗效及对其炎性和凝血指标等的影响[J].中国急救复苏与灾害医学杂志,2021,16(7):793-795,804.[4]杜娟,王若梅,陈婧,等.超短期胰岛素强化治疗对住院T2DM患者胰岛β细胞功能的影响[J].中国现代医学杂志,2021,31(10):84-88.[5]吕丹,刘秀玲,石燕萍,等.两种短期胰岛素强化治疗方案对不同HbA1c水平2型糖尿病患者的疗效及安全性比较[J].山东医药,2021,61(14):45-47.[6]应纪祥,冉兴无,钟莉,等.胰岛素泵与每日多次皮下注射胰岛素治疗1型糖尿病1年的疗效对比[J].西部医学,2021,33(3):415-418.[7]李霞,胡素琴,翁志强,等.三种胰岛素皮下注射方案对血糖治疗达标的2型糖尿病患者血糖变异性及低血糖发生率的影响[J].药学服务与研究,2021,21(1):41-44,51.[8]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志,2021,37(4):311-398.[9]俸东升,李远,邱锦媚,等.无针注射器和胰岛素笔皮下注射胰岛素控制初诊2型糖尿病患者血糖控制的效果的比较[J].广西医学,2020,42(20):2634-2638.[10]郭晨希,张士玉.胰岛素泵皮下注射与多次胰岛素皮下注射治疗糖尿病酮症疗效比较[J].临床军医杂志,2020,48(2):228-229.[11]代龙,徐素梅,曹华.动态血糖监测系统在评估不同胰岛素用药方式治疗T2DM的效果及对血糖变异性的影响观察分析[J].贵州医药,2020,44(1):24-26.[12]吴月丹,楼晓佳,周莉莉,等.持续皮下胰岛素输注和多次皮下胰岛素注射对高龄妊娠期糖尿病患者血糖波动及新生儿体质量的影响[J].中国妇幼保健,2019,34(22):5137-5140.[13]赵雪飘,谷敏,魏翠,等.胰岛素不同给药方式对妊娠期糖尿病患者围手术期血糖控制的效果研究[J].现代生物医学进展,2019,19(19):3674-3677.[14]牛瑞芝,钱曼丽.不同胰岛素方案对妊娠期糖尿病患者血糖控制和分娩结局的影响[J].中国妇幼保健,2019,34(19):4416-4418.[15]胡琛亮,奚宇,王玉婵,等.对新诊断2型糖尿病患者为期12周多次胰岛素类似物皮下注射强化治疗的疗效观察[J].中华全科医学,2019,17(10):1691-1693,1721.[16]练新兰,欧庆凤,李六民.胰岛素不同给药方式对高龄GDM患者血糖控制、母体及胎盘微炎症反应的影响比较[J].中国性科学,2019,28(9):54-57.[17]荣太梓,胡淑芳,程奎.短期持续胰岛素输注治疗初诊2型糖尿病的临床观察[J].中西医结合心脑血管病杂志,2018,16(22):3350-3352.[18]武春艳,郭晔.胰岛素持续泵入与皮下注射胰岛素对高龄妊娠期糖尿病孕妇血清HbA1c、Hcy、Cys-C水平及母婴结局的影响[J].临床和实验医学杂志,2018,17(21):2304-2307.[19]王建军,赵德运,张剑霄,等.糖尿病儿童胰岛素皮下注射及胰岛素泵治疗方法的药物经济学评价[J].中国妇幼健康研究,2018,29(4):477-480.[20]杨昕娉,周玲玲,梁成,等.2型糖尿病患者采用持续皮下胰岛素输注与胰岛素多次皮下注射治疗的成本效果比较研究[J].中国全科医学,2018,21(2):219-222.[21]何媛.不同胰岛素给药方法治疗糖尿病的疗效观察[J].中国急救医学,2018,38(1):133-133.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(17):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(17):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(17):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(17):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
　LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(17):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[7]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
　DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(17):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
[8]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
　LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[9]刘小红.长效胰岛素联合口服降糖药治疗2型糖尿病的 疗效与安全性评价[J].医学信息,2018,31(18):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
　LIU Xiao-hong.Efficacy and Safety of Long Acting Insulin Combined with Oral Hypoglycemic Agents in Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
[10]鲍 哲,杨升伟,柯赛赛,等.益生元对2型糖尿病患者糖脂代谢的影响[J].医学信息,2018,31(18):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]
　BAO Zhe,YANG Sheng-wei,KE Sai-sai,et al.Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus[J].Journal of Medical Information,2018,31(17):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]

更新日期/Last Update: 1900-01-01